Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1212/CPJ.0000000000000319 http://scihub22266oqcxt.onion/10.1212/CPJ.0000000000000319 C5964866!5964866!29849229     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Neurol+Clin+Pract 2017 ; 7 (1): 53-64 Nephropedia Template TP {{tp|p=29849229|t=2017. Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms |pdf=|usr=}}{{29849229}} gab.com Text Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms JO: Neurol Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=29849229 #FOAvip Background:: There are limited data to guide clinicians in differentiating tumefactive multiple sclerosis (TMS) from CNS neoplasms. Identifying distinguishing features will inform diagnosis and management and avoid unnecessary diagnostic biopsy. Our study aimed to determine the clinical and radiologic features that differentiate TMS from glioma and CNS lymphoma (CNSL) in patients who present with tumefactive lesions. Methods:: We retrospectively reviewed all patients with tumefactive lesions and histologically proven or clinically diagnosed TMS, glioma, or CNSL at our tertiary center from 1999 to 2012. Two independent blinded neuroradiologists rated MRI brain scans at presentation. We correlated patients' demographic, clinical, laboratory, and radiologic data to final diagnosis. Results:: A total of 133 patients (10 TMS, 85 glioma, 38 CNSL) were analyzed. Patients with TMS were younger and a greater proportion were women. Presenting symptoms did not distinguish between diagnoses. TMS lesions were smaller compared to glioma and CNSL, had no or mild mass effect, and were always associated with contrast enhancement. Radiologic features that were more frequent in TMS lesions were incomplete rim (open-ring) enhancement, incomplete peripheral diffusion restriction, and mixed T2 signal and CT hypoattenuation of MRI-enhancing components (all p < 0.05). Conclusions:: Radiologic features but not presenting symptoms are useful in distinguishing TMS from CNS neoplasms. Twit Text FOAVip Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms ????Neurol Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=29849229 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29849229 #FOAvip English Wikipedia <ref>{{Cite pmid|29849229}}</ref> Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms #MMPMID29849229 Lin X; Yu WY; Liauw L; Chander RJ; Soon WE; Lee HY; Tan K Neurol Clin Pract 2017[Feb]; 7 (1): 53-64 PMID29849229show ga Background:: There are limited data to guide clinicians in differentiating tumefactive multiple sclerosis (TMS) from CNS neoplasms. Identifying distinguishing features will inform diagnosis and management and avoid unnecessary diagnostic biopsy. Our study aimed to determine the clinical and radiologic features that differentiate TMS from glioma and CNS lymphoma (CNSL) in patients who present with tumefactive lesions. Methods:: We retrospectively reviewed all patients with tumefactive lesions and histologically proven or clinically diagnosed TMS, glioma, or CNSL at our tertiary center from 1999 to 2012. Two independent blinded neuroradiologists rated MRI brain scans at presentation. We correlated patients' demographic, clinical, laboratory, and radiologic data to final diagnosis. Results:: A total of 133 patients (10 TMS, 85 glioma, 38 CNSL) were analyzed. Patients with TMS were younger and a greater proportion were women. Presenting symptoms did not distinguish between diagnoses. TMS lesions were smaller compared to glioma and CNSL, had no or mild mass effect, and were always associated with contrast enhancement. Radiologic features that were more frequent in TMS lesions were incomplete rim (open-ring) enhancement, incomplete peripheral diffusion restriction, and mixed T2 signal and CT hypoattenuation of MRI-enhancing components (all p < 0.05). Conclusions:: Radiologic features but not presenting symptoms are useful in distinguishing TMS from CNS neoplasms. äClinicoradiologic features distinguish tumefactive multiple sclerosis (epmc).pdf DeepDyve Pubget Overpricing